CLINICAL TRIAL OF CREATINE IN ALS
$0M01FY2000RRNIH
University Of Texas Hlth Sci Ctr San Ant, San Antonio TX
Investigators
Linked publications & trials
Paper 38816203Paper 38746210Paper 38741246Paper 38204926Paper 38051041Paper 37978826Paper 37226675Paper 36933679Paper 36280384Paper 35926332Paper 35562076Paper 35453142Paper 35019976Paper 34753805Paper 34412057Paper 34219361Paper 34166655Paper 33707304Paper 33627633Paper 33597215Paper 33178459Paper 33168654Paper 33057385Paper 32845968Paper 32841523Paper 32564066Paper 32388179Paper 32281153Paper 32134326Paper 32128240Paper 32085906Paper 31898874Paper 31559418Paper 31338998Paper 31131339Paper 31112370Paper 30997482Paper 30900413Paper 30487263Paper 30421851Paper 30201101Paper 30065651Paper 29846553Paper 29545462Paper 29159267Paper 29086498Paper 29053861Paper 28958022Paper 28940967Paper 28678345Paper 28470881Paper 28031420Paper 27685338Paper 27676466Paper 27595918Paper 27471785Paper 27465756Paper 27271190Paper 27208378Paper 27142425Paper 27129676Paper 27114389Paper 27028282Paper 26833676Paper 26578543Paper 26489030Paper 26487792Paper 26386801Paper 26305897Paper 26094705Paper 26049399Paper 25887158Paper 25780952Paper 25707379Paper 25666468Paper 25592187Paper 25573655Paper 25546032Paper 25452229Paper 25405847Paper 25127483Paper 25102180Paper 25048381Paper 24986062Paper 24855155Paper 24853636Paper 24771618Paper 24763850Paper 24619151Paper 24533998Paper 24532116Paper 24445103Paper 24307184Paper 24273587Paper 24271651Paper 24174392Paper 24141640Paper 24081232Paper 24060607Paper 24029427
Abstract
This phase II, double-blind, placebo-controlled, randomized study is proposed to test the safety and efficacy of creatine, a non-pharmaceutical nutritional supplement, in 200 subjects with ALS. The primary outcome measure is change in disease progression rate as measured by maximum voluntary isometric contraction and strength of arm muscle groups.
View original record on NIH RePORTER →